Big Pharma follows cash-strapped seniors onto the darknet
29 October 2015
The existence of an ever-present pool of people who struggle to afford medicines and online bazaars that can meet their needs has brought two new groups to the hidden underbelly of the internet: Big Pharma and cash-strapped seniors
Sales reps need to bone up on tech skills as drug launches move digital
29 October 2015
Digitization in pharma means marketing integration doesn't end with websites and online campaigns. And the industry is looking at you, sales reps. Getting reps to master digital tools is a big opportunity, according to Nancy Phelan, head of the customer engagement center, worldwide customer operations for Bristol-Myers Squibb. In a recent keynote speech, Phelan talked up those tools and their positive effects on pharma brands, Medical Marketing & Media said in coverage of its leadership exchange conference.
MIT: Ultrasound gives GI drugs a quicker delivery with less discomfort
28 October 2015
Researchers from MIT--including drug delivery maven Robert Langer--and Massachusetts General Hospital have found a quick way to deliver drugs to the gastrointestinal tract using ultrasound, someday improving treatment of disorders there such as inflammatory bowel disease, ulcerative colitis and Crohn's disease.
India needs to help solve global problem of antibiotic overuse
28 October 2015
India needs to step up to the plate and help industries across the globe stop overuse of antibiotics, which leads to many diseases becoming multidrug-resistant, according to the head of a British commission looking into the problem.
As biotech selling spreads, more weakness seen for U.S. health stocks
28 October 2015
Selling has spread from biotechs - shaken on Sept. 21 when Hillary Clinton first tweeted concerns about drug prices - to other areas of the healthcare sector. Investors have been dumping shares of everything from hospitals to traditional pharmaceutical companies and insurers in recent weeks.
Asia's dengue epidemic highlights race for treatment, vaccine options
27 October 2015
A sharp rise in dengue fever is earning it the notorious title as the world's fastest-spreading tropical disease with new outbreaks engulfing the Asian continent, crippling hospital services and forcing facilities to turn away patients, according to a Reuters report.
Immunotherapy creates fresh challenges and tactical imperatives
27 October 2015
With widespread excitement about immuno-oncology combinations driving deals, the pressure to find synergies has never been greater. The opportunities are creating new challenges for companies big and small, executives at the 2015 BIO Investor Forum said.
Marinus Announces Key Initial Observations From Study in PCDH19 Female Pediatric Epilepsy
26 October 2015
Marinus Pharmaceuticals, Inc., a biopharmaceutical company dedicated to the development of innovative therapeutics to treat epilepsy and neuropsychiatric disorders, today announced key observations from patients enrolled in its ongoing study evaluating ganaxolone, a synthetic analog of the endogenous neurosteroid allopregnanolone, as a treatment for PCDH19 female pediatric epilepsy. PCDH19 is a serious and rare epileptic syndrome characterized by highly variable early-onset cluster seizures, and cognitive and behavioral disturbances. Enrollment is continuing in the study with full data expected in 2016.
Even in a down market, the drumbeat for dollars continues to sound out
26 October 2015
BIO Investor will provide a platform for more than 180 company presentations by discovery companies – defined by BIO as those that have raised less than $25 million in seed or series A rounds – established private companies that have raised more than $25 million in series B and later rounds, and emerging public companies. As observed in this week’s BioWorld Insight analysis of the roiling capital markets, this group of companies will feel the pinch first if the bottom drops out for biopharma.
Google's med tech allure draws top scientists and academics
26 October 2015
Google is good at getting what it wants, as evidenced by its recent deals with device and biotech companies through its fast-growing Life Science group. And the tech titan's allure has also attracted some of the industry's top scientists, who left their positions in the research and academic fields to further Google's med tech ambitions.
14 March 2024
26 February 2024
NovaMedica team wishes you a Merry Christmas and a Happy New Year!
26 December 2023
Big Pharma’s ROI for drug R&D saw 'welcome' rebound in 2023: report
25 April 2024
Orphan drug market to reach $270B by 2028 : Evaluate
25 April 2024
Russian drug for the treatment of viral hepatitis will be exempt from duty in Mongolia
24 April 2024
PM Mishustin: “We need to increase the production of vital and essential drugs in Russia”
24 April 2024